Eliane Louise Laplace

Title: The Innovative Contributions of Eliane Louise Laplace

Introduction

Eliane Louise Laplace, an inventor based in Oullins, France, has made significant strides in the field of avian vaccines, holding a total of five patents. Her work focuses on developing innovative vaccine formulations aimed at enhancing the health and welfare of avian species through advanced biotechnological approaches.

Latest Patents

Among her latest patents is the "Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis." This live vaccine incorporates an ILTV virus that expresses heterologous nucleotide sequences. These sequences are strategically placed within the intergenic region that lies between stop codons of specific open reading frames (ORF D and ORF E) of the ILTV strain. The innovation allows for the insertion of sequences derived from various avian pathogens, controlled by a strong eukaryotic promoter like the CMV-IE promoter.

Another notable patent is for a "Live recombinant avian vaccine using an avian herpesvirus as a vector." This vaccine employs an avian herpesvirus that includes at least one nucleotide sequence encoding an antigenic polypeptide, thereby creating robust immune responses against avian pathogens. This vaccine also utilizes the CMV immediate early promoter for effective expression and can be formulated as a polyvalent vaccine encompassing multiple antigenic sequences.

Career Highlights

Eliane Louise Laplace has worked with esteemed companies such as Merial Limited and Rhone Merieux, contributing her expertise in vaccine development that has helped to shape innovative approaches for avian health management. Her career reflects a dedication to pushing the boundaries of biotechnological innovations within the field.

Collaborations

Throughout her career, Eliane has collaborated with notable peers including Michel Joseph Bublot and Jean-Christophe Francis Audonnet. These collaborations have not only enhanced her research but also contributed to the shared goal of advancing veterinary science through innovative vaccine solutions.

Conclusion

Eliane Louise Laplace exemplifies the spirit of innovation in the development of avian vaccines. With her numerous patents and collaborations with industry leaders, she continues to make impactful contributions to the field of animal health. Her work is a testament to the power of inventive thinking in addressing contemporary challenges in veterinary medicine.